Curian Capital’s Thermo Fisher Scientific TMO Stock Holding History

Curian Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-5,079	Closed	-$621K	–	547
2015 Q3	$621K	Sell	5,079 -5,549	-52%	-$723K	0.02%	457
2015 Q2	$1.38M	Buy	10,628 +2,877	+37%	+$375K	0.02%	394
2015 Q1	$1.04M	Sell	7,751 -1,036	-12%	-$134K	0.02%	458
2014 Q4	$1.1M	Buy	8,787 +1,627	+23%	+$198K	0.02%	428
2014 Q3	$871K	Buy	7,160 +79	+1%	+$9.61K	0.02%	452
2014 Q2	$836K	Sell	7,081 -670	-9%	-$78.9K	0.01%	468
2014 Q1	$932K	Sell	7,751 -102,859	-93%	-$12.2M	0.02%	449
2013 Q4	$12.3M	Buy	110,610 +2,922	+3%	+$291K	0.22%	109
2013 Q3	$9.92M	Buy	107,688 +1,484	+1%	+$134K	0.18%	123
2013 Q2	$8.99M	Buy	+106,204	New	+$8.84M	0.16%	123

Other funds holding TMO

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Curian Capital's TMO Position: Q4 2015 in Review

Curian Capital sold out of Thermo Fisher Scientific (TMO) in Q4 2015, closing a stake of 5,079 shares — an estimated $621K sold.

Curian Capital first reported a position in TMO in Q2 2013 and held it in 10 quarters. The position peaked at $12.3M in Q4 2013. 1,006 funds tracked by Wall St. Rank hold TMO as of Q4 2015.

Curian Capital reported no remaining Thermo Fisher Scientific position as of Q4 2015 after selling out during the quarter.
Curian Capital sold 5,079 Thermo Fisher Scientific shares in Q4 2015, an estimated $621K.
Curian Capital first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 10 quarters.
Curian Capital's Thermo Fisher Scientific position peaked at $12.3M in Q4 2013.
1,006 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2015.

Based on Curian Capital's 13F filing for Q4 2015, filed 25 Jan 2016.